LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 285 of 520
Next
>>
>
7101 to 7125 of 12982 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	WYE-125132	0.12	uM	LJP6	2	L11	72	hr	1334	2128	3899	0.5458	0.3520
BT-20	WYE-125132	0.12	uM	LJP6	3	L11	72	hr	1334	2045	3921	0.5215	0.3158
BT-20	WYE-125132	0.37	uM	LJP6	1	L10	72	hr	1334	1977	3955	0.4998	0.2849
BT-20	WYE-125132	0.37	uM	LJP6	2	L10	72	hr	1334	1909	3899	0.4896	0.2604
BT-20	WYE-125132	0.37	uM	LJP6	3	L10	72	hr	1334	1855	3921	0.4731	0.2358
BT-20	WYE-125132	1.11	uM	LJP6	1	L09	72	hr	1334	1843	3955	0.4659	0.2286
BT-20	WYE-125132	1.11	uM	LJP6	2	L09	72	hr	1334	1700	3899	0.4360	0.1693
BT-20	WYE-125132	1.11	uM	LJP6	3	L09	72	hr	1334	1653	3921	0.4215	0.1475
BT-20	WYE-125132	3.33	uM	LJP6	1	L08	72	hr	1334	1631	3955	0.4123	0.1365
BT-20	WYE-125132	3.33	uM	LJP6	2	L08	72	hr	1334	1569	3899	0.4024	0.1102
BT-20	WYE-125132	3.33	uM	LJP6	3	L08	72	hr	1334	1560	3921	0.3978	0.1055
BT-20	WYE-125132	10	uM	LJP6	1	L07	72	hr	1334	1456	3955	0.3681	0.0571
BT-20	WYE-125132	10	uM	LJP6	2	L07	72	hr	1334	1478	3899	0.3791	0.0682
BT-20	WYE-125132	10	uM	LJP6	3	L07	72	hr	1334	1416	3921	0.3611	0.0388
BT-20	Barasertib	0.04	uM	LJP5	1	D12	72	hr	1334	3039	3930	0.7731	0.6956
BT-20	Barasertib	0.04	uM	LJP5	2	D12	72	hr	1334	3228	4051	0.7968	0.7356
BT-20	Barasertib	0.04	uM	LJP5	3	D12	72	hr	1334	3767	4117	0.9148	0.8934
BT-20	Barasertib	0.12	uM	LJP5	1	D11	72	hr	1334	2322	3930	0.5907	0.4267
BT-20	Barasertib	0.12	uM	LJP5	2	D11	72	hr	1334	2292	4051	0.5658	0.4016
BT-20	Barasertib	0.12	uM	LJP5	3	D11	72	hr	1334	3160	4117	0.7674	0.6994
BT-20	Barasertib	0.37	uM	LJP5	1	D10	72	hr	1334	1834	3930	0.4666	0.2262
BT-20	Barasertib	0.37	uM	LJP5	2	D10	72	hr	1334	1774	4051	0.4379	0.1944
BT-20	Barasertib	0.37	uM	LJP5	3	D10	72	hr	1334	2234	4117	0.5425	0.3729
BT-20	Barasertib	1.11	uM	LJP5	1	D09	72	hr	1334	1493	3930	0.3798	0.0746
BT-20	Barasertib	1.11	uM	LJP5	2	D09	72	hr	1334	1494	4051	0.3688	0.0729

|<
<<
Previous
Page 285 of 520
Next
>>
>
7101 to 7125 of 12982 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)